Effect of intravenous alteplase on post‐stroke depression in the WAKE UP trial
Alina Königsberg(Universität Hamburg), Florent Boutitie(Université Claude Bernard Lyon 1), Götz Thomalla(Universität Hamburg), Joaquı́n Serena(Universität Hamburg), Robin Lemmens(VIB-KU Leuven Center for Microbiology), Salvador Pedraza(Hospital Clínic de Barcelona), Bastian Cheng(Universität Hamburg), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Keith W. Muir(University of Glasgow), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Susanne Sehner(Lyon 1 Université), Martin Ebinger(Universität Hamburg), Sönke Arlt(Evangelisches Krankenhaus Alsterdorf), Christian Gerloff(Universität Hamburg), Jochen B. Fiebach(Pathodiagnostik Berlin), Matthias Endres(German Center for Neurodegenerative Diseases), Claus Z. Simonsen(Universität Hamburg)
Cited by 8
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
|New England Journal of Medicine|2018|856